22157.jpg
Degenerative Disc Disease Market Forecast - 2032; NSAIDs, Opioids, and others are major revenue generators
12 avr. 2024 10h28 HE | Research and Markets
Dublin, April 12, 2024 (GLOBE NEWSWIRE) -- The "Degenerative Disc Disease - Market Insight, Epidemiology and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.Key...
22157.jpg
Degenerative Disc Disease Drug Pipeline Research Report 2024 Featuring Spine BioPharma, Angitia Biopharmaceuticals, Mesoblast, BioRestorative Therapies, and DiscGenics, Inc.
11 avr. 2024 09h08 HE | Research and Markets
Dublin, April 11, 2024 (GLOBE NEWSWIRE) -- The "Degenerative Disc Disease - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Degenerative Disc...
Logo.png
DelveInsight Highlights Major Advances, Transformative Therapies, and 15+ Leading Players Wheeling the Degenerative Disc Disease Pipeline Landscape
20 févr. 2023 13h00 HE | DelveInsight Business Research LLP
New York, USA, Feb. 20, 2023 (GLOBE NEWSWIRE) -- DelveInsight Highlights Major Advances, Transformative Therapies, and 15+ Leading Players Wheeling the Degenerative Disc Disease Pipeline Landscape ...